Arii S - Search Results

1

Splenic artery ligation: A protection against hepatic ischemia/reperfusion injury in partially hepatectomized rats.

Irie T, Ito K, Ozasa H, Noda Y, Ikeda S, Tanaka S, Arii S, Horikawa S. Irie T, et al. Among authors: arii s. Hepatol Res. 2012 Aug;42(8):819-27. doi: 10.1111/j.1872-034X.2012.00989.x. Epub 2012 Apr 2. Hepatol Res. 2012. PMID: 22469310

2

Splenic artery ligation improves remnant liver function in partially hepatectomized rats with ischemia/reperfusion injury.

Ito K, Ozasa H, Noda Y, Koike Y, Arii S, Horikawa S. Ito K, et al. Among authors: arii s. Liver Int. 2007 Apr;27(3):400-7. doi: 10.1111/j.1478-3231.2006.01432.x. Liver Int. 2007. PMID: 17355463

3

Effects of free radical scavenger on acute liver injury induced by d-galactosamine and lipopolysaccharide in rats.

Ito K, Ozasa H, Noda Y, Arii S, Horikawa S. Ito K, et al. Among authors: arii s. Hepatol Res. 2008;38(2):194-201. doi: 10.1111/j.1872-034X.2007.00252.x. Epub 2007 Aug 28. Hepatol Res. 2008. PMID: 17727650

4

Effect of non-essential amino acid glycine administration on the liver regeneration of partially hepatectomized rats with hepatic ischemia/reperfusion injury.

Ito K, Ozasa H, Noda Y, Koike Y, Arii S, Horikawa S. Ito K, et al. Among authors: arii s. Clin Nutr. 2008 Oct;27(5):773-80. doi: 10.1016/j.clnu.2008.06.012. Epub 2008 Aug 8. Clin Nutr. 2008. PMID: 18692283

5

The close participation of ET-1 and NO in human hepatic hemodynamics.

Noguchi N, Teramoto K, Ochiai T, Irie T, Kudou A, Kurokawa T, Nakamura N, Tanaka S, Kawamura T, Arii S. Noguchi N, et al. Among authors: arii s. Hepatol Res. 2006 Oct;36(2):86-93. doi: 10.1016/j.hepres.2006.07.002. Hepatol Res. 2006. PMID: 17027597

6

Does the preoperative alpha-fetoprotein predict the recurrence and mortality after hepatectomy for hepatocellular carcinoma without macrovascular invasion in patients with normal liver function?

Kudo A, Matsumura S, Ban D, Irie T, Ochiai T, Tanaka S, Arii S, Tanabe M. Kudo A, et al. Among authors: arii s. Hepatol Res. 2014 Dec;44(14):E437-46. doi: 10.1111/hepr.12335. Epub 2014 May 6. Hepatol Res. 2014. PMID: 24690156

7

The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma.

Aihara A, Tanaka S, Yasen M, Matsumura S, Mitsunori Y, Murakata A, Noguchi N, Kudo A, Nakamura N, Ito K, Arii S. Aihara A, et al. Among authors: arii s. J Hepatol. 2010 Jan;52(1):63-71. doi: 10.1016/j.jhep.2009.10.013. Epub 2009 Oct 29. J Hepatol. 2010. PMID: 19913935

8

Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma.

Tanaka S, Arii S. Tanaka S, et al. Among authors: arii s. Int J Clin Oncol. 2006 Apr;11(2):82-9. doi: 10.1007/s10147-006-0566-5. Int J Clin Oncol. 2006. PMID: 16622743 Review.

9

Decreased Mrp2-dependent bile flow in the post-warm ischemic rat liver.

Ban D, Kudo A, Sui S, Tanaka S, Nakamura N, Ito K, Suematsu M, Arii S. Ban D, et al. Among authors: arii s. J Surg Res. 2009 May 15;153(2):310-6. doi: 10.1016/j.jss.2008.02.064. Epub 2008 Mar 31. J Surg Res. 2009. PMID: 18662814

10

Molecularly targeted therapy for hepatocellular carcinoma.

Tanaka S, Arii S. Tanaka S, et al. Among authors: arii s. Cancer Sci. 2009 Jan;100(1):1-8. doi: 10.1111/j.1349-7006.2008.01006.x. Epub 2008 Nov 25. Cancer Sci. 2009. PMID: 19038007 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters